摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(羟基甲基)-1-甲基嘧啶-2,4-二酮 | 79719-31-6

中文名称
3-(羟基甲基)-1-甲基嘧啶-2,4-二酮
中文别名
——
英文名称
3-hydroxymethyl-1-methyluracil
英文别名
2,4(1H,3H)-Pyrimidinedione, 3-(hydroxymethyl)-1-methyl-;3-(hydroxymethyl)-1-methylpyrimidine-2,4-dione
3-(羟基甲基)-1-甲基嘧啶-2,4-二酮化学式
CAS
79719-31-6
化学式
C6H8N2O3
mdl
——
分子量
156.141
InChiKey
NJPKFSOHVCQDQX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.6
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    60.8
  • 氢给体数:
    1
  • 氢受体数:
    3

SDS

SDS:24a11b612c3358c763d7f55561a90ad9
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    1-甲基尿嘧啶聚合甲醛 在 pH 4.05 作用下, 以 为溶剂, 生成 3-(羟基甲基)-1-甲基嘧啶-2,4-二酮
    参考文献:
    名称:
    氮杂环的N-羟甲基衍生物作为可能的前药I:尿嘧啶的N-羟甲基化。
    摘要:
    制备了1,3-二羟甲基尿嘧啶,3-羟甲基-1-甲基尿嘧啶和1-羟甲基-3-甲基尿嘧啶的固体样品,并通过光谱分析确认了它们的结构。还研究了在甲醛水溶液中形成N-羟甲基化尿嘧啶的热力学和动力学。用于形成N-1-羟甲基衍生物的平衡常数大约是用于形成N-3-羟甲基衍生物的平衡常数的两倍,并且它们在整个pH 3--8范围内的形成速度更快。尿嘧啶C-5处的取代基对N-羟甲基化的热力学影响很小。讨论了N-羟甲基化合物作为前药的潜在用途。
    DOI:
    10.1002/jps.2600700803
点击查看最新优质反应信息

文献信息

  • Derivatives Of Chemotherapeutic Agents With A Formaldehyde Releasing Moiety
    申请人:Nudelman Abraham
    公开号:US20070293517A1
    公开(公告)日:2007-12-20
    Novel conjugates of chemotherapeutic agents, which are designed so as to release formaldehyde or analogs thereof upon cleavage, processes of preparing same, pharmaceutical compositions containing same and methods utilizing same for treating medical conditions such as cancer, immune-mediated diseases, viral infections and diseases, bacterial infections and diseases, fungal infections and diseases, protozal infections and diseases and more, and particularly for treating such conditions which are characterized by drug resistance are provided.
  • [EN] NOVEL DERIVATIVES OF CHEMOTHERAPEUTIC AGENTS AND USES THEREOF<br/>[FR] DERIVES D'AGENTS CHIMIOTHERAPEUTIQUES ET UTILISATIONS
    申请人:UNIV RAMOT
    公开号:WO2005120577A2
    公开(公告)日:2005-12-22
    Novel conjugates of chemotherapeutic agents, which are designed so as to release formaldehyde or analogs thereof upon cleavage, processes of preparing same, pharmaceutical compositions containing same and methods utilizing same for treating medical conditions such as cancer, immune-mediated diseases, viral infections and diseases, bacterial infections and diseases, fungal infections and diseases, protozal infections and diseases and more, and particularly for treating such conditions which are characterized by drug resistance are provided.
  • N-hydroxymethyl Derivatives of Nitrogen Heterocycles as Possible Prodrugs I: N-hydroxymethylation of Uracils
    作者:Padam C. Bansal、Ian H. Pitman、Josiah N.S. Tam、Mathias Mertes、James J. Kaminski
    DOI:10.1002/jps.2600700803
    日期:1981.8
    constants for formation of N-1-hydroxymethyl derivatives were approximately twice those for formation of N-3-hydroxymethyl derivatives, and they were formed more rapidly throughout the pH 3--8 range. Substituents at C-5 of uracil had little effect on the thermodynamics of N-hydroxymethylation. The potential usefulness of N-hydroxymethyl compounds as prodrugs is discussed.
    制备了1,3-二羟甲基尿嘧啶,3-羟甲基-1-甲基尿嘧啶和1-羟甲基-3-甲基尿嘧啶的固体样品,并通过光谱分析确认了它们的结构。还研究了在甲醛水溶液中形成N-羟甲基化尿嘧啶的热力学和动力学。用于形成N-1-羟甲基衍生物的平衡常数大约是用于形成N-3-羟甲基衍生物的平衡常数的两倍,并且它们在整个pH 3--8范围内的形成速度更快。尿嘧啶C-5处的取代基对N-羟甲基化的热力学影响很小。讨论了N-羟甲基化合物作为前药的潜在用途。
查看更多